Showing results (181-190 of 196) with videos related to
Sort By:
Pageof 20
Eclinicalmedicine|March 11, 2026
Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort studyMaria Vincenza Mastrolia, Vignesh Pandiarajan, Marco Cattalini, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 12, 2021
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factorsAlessandro Orsini, Thomas Foiadelli, Mariasole Magistrali, et al.Journal of Autoimmunity|April 19, 2025
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational studyMarta Bustaffa, Saverio La Bella, Yagmur Bayindir, et al.Pediatric Rheumatology Online Journal|May 1, 2025
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature reviewNatalia Vasquez Canizares, Clare E Pain, Francesco Zulian, et al.Paediatrics & Child Health|December 1, 2025
The landscape of inter-institutional and multinational collaborations in Kawasaki diseaseRocio Gutierrez Rojas, Fabiola Breault, Raed Alzyoud, et al.Clinical and Experimental Rheumatology|March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody productsRosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.RMD Open|November 21, 2023
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.Annals of the Rheumatic Diseases|February 18, 2025
TEMPORARY REMOVAL: EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO)Yongdong Zhao, Melissa S Oliver, Anja Schnabel, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 9, 2025
EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial OsteomyelitisYongdong Zhao, Melissa S Oliver, Anja Schnabel, et al.Pageof 20